Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
UJAN: Understanding Innovator's Ultra Buffer ETF – January Strategy

UJAN: Understanding Innovator's Ultra Buffer ETF – January Strategy

Key Takeaways

  • UJAN is the Innovator U.S. Equity Ultra Buffer ETF – January, an actively managed "defined outcome" exchange-traded fund (ETF) issued by Innovator Capital Management.
  • The fund seeks to match the price return of the SPDR S&P 500 ETF Trust (SPY) up to a set upside cap while buffering losses between 5% and 35% over a one-year outcome period.
  • Its outcome period resets each January, and its upside cap and downside buffer are recalculated annually based on prevailing market conditions.
  • UJAN carries a net expense ratio of 0.79% and is listed on the Cboe BZX exchange.
  • The strategy is designed for risk-conscious investors seeking U.S. large-cap equity exposure with a built-in downside cushion, in exchange for capped upside.

Getting to Know UJAN

UJAN represents one of the defined outcome ETFs from Innovator Capital Management. These products aim to deliver a predetermined range of returns over a set timeframe instead of simply mirroring an index through every market move. What draws attention to UJAN is its focus on S&P 500 large-cap exposure combined with an effort to cushion against moderate declines, which can appeal to investors who want equity participation without full downside exposure.

The Fund's Structure and Holdings

Launched with an inception on December 31, 2018, and first trading on January 2, 2019, UJAN does not follow a traditional index in a direct manner. Its goal is to align with the price return of the SPDR S&P 500 ETF Trust (SPY) up to an upside cap while providing a buffer against losses between 5% and 35% during the annual outcome period from January 1 to December 31. To implement this, the fund primarily holds FLEX Options tied to SPY, along with short-term cash collateral. For the 2026 period, the upside cap stands at 11.40% before fees, translating to roughly 10.61% after the 0.79% expense ratio. Sector exposure tends to reflect the S&P 500 broadly, with heavier weighting toward information technology, financials, communication services, and healthcare. I also checked this using Tickeron’s AI Screener to compare its profile with peers.

Why This ETF Draws Interest

Investors often consider UJAN for its clearly defined payoff structure rather than unlimited market participation. The key feature is the downside buffer, which targets absorption of losses in SPY from the 5% to 35% range over the outcome period. Holders still absorb the initial 5% of any drop and anything beyond 35%, yet the mechanism can moderate the impact of typical drawdowns. This setup suits those seeking U.S. large-cap exposure with some protection, such as investors nearing retirement or looking to add a defensive element to an equity allocation. The trade-off remains the upside cap, which can cause the fund to lag a standard S&P 500 holding during strong rallies. In my view, it functions best as a complement to core index funds in environments that are flat to down.

Potential Drawbacks to Consider

Opportunity cost stands out as the primary risk because the cap can lead to underperformance versus SPY in years of substantial gains. The cap resets each January and varies with market conditions. The buffer itself has limits: it excludes the first 5% of losses and does not extend beyond 35%. Severe declines can still result in notable losses. Outcomes are intended for full-period holders; mid-period trades may alter results. As a non-diversified fund relying on a limited set of options, it also involves tracking and counterparty elements, and the 0.79% expense ratio exceeds that of many plain index ETFs. From what I see, these factors warrant close attention when sizing a position.

Final Thoughts

UJAN provides a structured approach to equity exposure through its annual reset of capped upside and defined downside buffer. Its value centers on predictability and drawdown management rather than maximum returns, which can make it worth evaluating for portfolios that emphasize capital preservation across market cycles.

Enhancing ETF Research with AI Tools

When comparing buffered ETFs like UJAN to other securities, I frequently rely on Tickeron's AI Screener to apply technical, fundamental, and volatility filters across large universes. This helps surface ideas that align with specific risk-managed strategies without manual screening of thousands of options.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UJAN

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


UJAN in downward trend: price dove below 50-day moving average on November 16, 2026

UJAN moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 17 of 31 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 55%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 20 of 64 cases where UJAN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 31%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UJAN as a result. In 30 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 39%.

The Moving Average Convergence Divergence Histogram (MACD) for UJAN turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 19 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 38%.

The 10-day moving average for UJAN crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UJAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.

Bullish Trend Analysis

Following a +1.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where UJAN advanced for three days, in 249 of 391 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

UJAN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 334 of 474 cases where UJAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.

Industry description

The investment seeks the fund seeks to provide investors with returns that match the return of the Underlying ETF, up to the upside cap of 11.40% while providing a buffer against Underlying ETF losses of between 5% and 35% (prior to taking into account management fees and other fees), over the period from January 1, 2026 to December 31, 2026. The fund advisor has adopted a policy pursuant to Rule 35d-1 under the 1940 Act to invest, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in investments that provide exposure to the State Street® SPDR® S&P 500® ETF Trust. The fund is non-diversified.
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.